Drugmakers are investing more in U.S. manufacturing as President Donald Trump threatens tariffs, but facilities can take ...

Genentech plans a $700 million biotech facility in Holly Springs, NC, creating 420 high-paying jobs. State and local incentives total $46 million.

Genentech, a member of the Roche Group, will create 400 jobs with a new biotechnology facility in Holly Springs, Wake County, North Carolina.

Roche and Genentech Announce New North Carolina Manufacturing Facility Future 700,000 sq. ft. facility in Holly Springs, NC, will support pharma division’s metabolic medicines portfolio ...

Genentech, American-headquartered in San Francisco and subsidiary of the Roche Group headquartered in Basel, Switzerland, plans 420 jobs for the Wake County community of Holly Springs just outside ...

Genentech, American-headquartered in San Francisco and subsidiary of the Roche Group headquartered in Basel, Switzerland, plans 420 jobs for the Wake County community of Holly Springs just outside ...

Genentech, American-headquartered in San Francisco and subsidiary of the Roche Group headquartered in Basel, Switzerland, plans 420 jobs for the Wake County community of Holly Springs just outside ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today plans to invest more than $700 million in a new 700,000 square ...

Roche announces new Genentech plant in Holly Springs, North Carolina as Wake County town adds jobs from another biopharma giant to list of Fujifilm, Amgen, CSL Seqirus ...